A61K 9/288
Compounds of unknown constitution
Official title: {Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/282)}
A61K9/288 (Compounds of unknown constitution) appears on 81 US grants and 159 published applications in this corpus.
Search patents in A61K- Granted patents
- 81
- Published applications
- 159
- Assignees
- 74
- Inventors
- 274
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 0 | 4 |
| 2010 | 0 | 6 |
| 2011 | 1 | 11 |
| 2012 | 3 | 6 |
| 2013 | 2 | 8 |
| 2014 | 6 | 13 |
| 2015 | 7 | 18 |
| 2016 | 14 | 16 |
| 2017 | 9 | 11 |
| 2018 | 6 | 9 |
| 2019 | 7 | 13 |
| 2020 | 7 | 8 |
| 2021 | 5 | 4 |
| 2022 | 5 | 6 |
| 2023 | 3 | 6 |
| 2024 | 1 | 8 |
| 2025 | 3 | 2 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Extended release composition of 2-(2-Aminothiazol-4-yl)-N-[4-(2{[(2R)-2-hydroxy-2-phenylethyl] amino} ethyl) phenyl] acetamide21 Apr 2026US 12,605,340 B2Zim Laboratories Limited
- Tablets having discontinuous coated regions31 Mar 2026US 12,589,074 B2Kenvue Brands LLC
- Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization29 Apr 2025US 12,285,035 B2Christalfarma S.R.L.
- Tablet dosage formulations of oleyl phosphocholine4 Feb 2025US 12,214,081 B2Oblita Therapeutics BVBA
- Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension21 Jan 2025US 12,201,726 B2Catalent U.K. Swindon Zydis Limited
- Protein Based Soft Chew Tablets28 May 2026US 2026/0144746 A1Fertin Pharma A/S
- Ticagrelor solid dispersion, method for preparing same, and use thereof15 Jan 2026US 2026/0014155 A1Wisdom Pharmaceutical Co., Ltd
- New coating system (i)23 Oct 2025US 2025/0325487 A1Dsm IP Assets B.V.
- New coating system (ii)6 Feb 2025US 2025/0041230 A1Dsm IP Assets B.V.
- Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 27 Nov 2024US 2024/0366591 A1Auspex Pharmaceuticals, Inc.
Most cited
By later US patents
- Enterically coated cystamine, cysteamine and derivatives thereof26US 8,026,284 B2The Regents of the University of California · 2011
- Enterically coated cysteamine, cystamine and derivatives thereof24US 8,129,433 B2The Regents of the University of California · 2012
- Pulsatile drug release21US 9,474,719 B2University of Strathclyde · 2016
- Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection19US 9,370,528 B2Volant Holdings GmbH · 2016
- Pharmaceutical compositions resistant to abuse18US 8,603,526 B2Egalet Ltd. · 2013